Ozempic raises healthcare costs, whether you can get it or not
About 165 million Americans rely on employer-sponsored health insurance, and yet workers still may not get the coverage they want,…
pharmaceutical products
Pfizer threatened renegade executives before schism: Starboard's Smith
Ian Read, former CEO of Pfizer Inc., gestures as he speaks during a panel session at the World Economic Forum…
Novo Nordisk's Ozempic may reduce risk of opioid overdose, study finds
A box of Ozempic manufactured by Novo Nordisk is seen at a pharmacy in London, Britain, March 8, 2024. Hollie…
Novo Nordisk CEO to testify before Senate on weight loss drug prices
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, speaks during an interview in New York on August 10, 2022. Christopher Goodney…
Why Eli Lilly and Palo Alto Networks are keeping up with their competitors
Every weekday, the CNBC Investment Club with Jim Cramer publishes Homestretch, a handy evening update, just in time for the…
FTC sues drug brokers for allegedly inflating insulin prices
Federal Trade Commission (FTC) Chair Lina Khan testifies before the House Appropriations Subcommittee in the Rayburn House Office Building on…
Novartis CEO says it won't join weight-loss drug frenzy
The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…
Pfizer's drug for cancer cachexia shows positive results in mid-phase trials
PfizerPfizer's experimental drug for a common, potentially fatal disease that causes cancer patients to lose appetite and weight showed positive…
Florida advises against the use of mRNA vaccines against Covid in older adults
As the Covid wave continues in Florida, Gov. Ron DeSantis' administration is again advising against mRNA vaccines — this time…
Noom to offer GLP-1 drug through new weight loss program
Digital health company Noom announced Thursday that it will offer a compounded GLP-1 drug as part of a new weight-loss…